SIGN UP
LOG IN
M
MRUS
Merus
41.60
-1.61-3.73%After Hours: 47.89 +6.29 +15.12%19:59 05/22 EDT
OPEN/PREV CLOSE42.47/43.21
TODAY RANGE41.50-43.09
VOL1.94M
MARKET CAP2.88B
52 WEEK RANGE33.19-61.61
AVG VOL (3M)836.94K
% TURNOVER2.80%
TURNOVER--
P/E (TTM)-10.0941
% RANGE3.68%
EPS(TTM)-4.1212
P/E(FORWARD)-21.8947
P/B4.827
BVPS8.62
DIVIDEND--
P/S79.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.78B
SHARES OUTSTANDING69.21M
NEXT EARNINGS07/30-08/04
FREE FLOAT66.86M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·6h ago
Merus updates on Petosemtamab+Pembrolizumab data in HNSCC
Seeking Alpha·13h ago
Prices of new U.S. drugs doubled over the past four years: report
TipRanks·18h ago
Merus Shareholders Approve Key Proposals at AGM
TipRanks·3d ago
Truist Financial Reaffirms Their Buy Rating on Merus (MRUS)
Dow Jones·3d ago
Merus Price Target Maintained With a $75.00/Share by Needham
Benzinga·3d ago
Needham Reiterates Buy on Merus, Maintains $75 Price Target
TipRanks·05/15 14:27
Merus (MRUS) Gets a Buy from Guggenheim
TipRanks·05/15 12:38
Merus announces publication on mechanism of action of petosemtamab
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.